Reporter NameRelationshipTypeAmountSEC FilingGao HanlinChief Scientific OfficerSell$11,782Form 4Xie JianPresident and COOSell$14,965Form 4
Fulgent Genetics’ executives have recently sold shares to meet tax obligations related to the vesting of restricted stock units.
Gao Hanlin, the company’s Chief Scientific Officer, sold 548 shares of Common Stock on August 25, 2025, at a weighted-average price of $21.5016 per share, totaling $11,782. Following this transaction, Gao Hanlin directly owns 959,091 shares of Fulgent Genetics.
Xie Jian, Fulgent Genetics President and COO, sold 696 shares of Common Stock on the same date, at the same weighted-average price of $21.5016 per share, totaling $14,965. After the sale, Xie Jian directly owns 366,448 shares and indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.